Research programme: anti-inflammatory antibodies - IMIDomics/ Twist Bioscience Corporation
Alternative Names: anti-inflammatory antibodies - IMIDomics/ Twist Bioscience Corporation; Immune-mediated inflammatory disease antibodies - IMIDomics/Twist BioscienceLatest Information Update: 21 Nov 2023
At a glance
- Originator IMIDomics; Twist Bioscience
- Class Anti-inflammatories; Antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Inflammation